E2095. Musculoskeletal Oncologic Interventions: Applications in Palliative Pain Control in Soft Tissue and Osseous Metastatic Disease
Authors
Darren Chan;
Vancouver General Hospital
Peter Munk;
Vancouver General Hospital
Paul Mallinson;
Vancouver General Hospital
Hugue Ouellette;
Vancouver General Hospital
Adnan Sheikh;
Vancouver General Hospital
Background
Musculoskeletal oncology intervention (MSK OI) is an emerging application for oncological patients that compliments traditional arms of treatment including surgery, radiation, and medical therapy. The evolution of practice in this area particularly addresses a gap in treatment when surgery and radiation therapy are no longer viable with an emphasis on pain management and prevention of skeletal related events leading to improvement in quality of life. Our local practice of a provincial wide multidisciplinary team has increased clinician awareness, facilitated complex therapeutic decisions and improved patient accessibility. The main focus of MSK OI is addressing pain management and prevention of skeletal related events leading to improvement in quality of life. Delays in the referral process may result in disease progression or pathological fracture rendering patient’s unsuitable for MSK OI. Currently radiotherapy remains the mainline treatment for the management of painful osseous metastases. Similarly, MSK OI primarily addresses painful soft tissue and osseous metastatic disease. Other potential benefits include improving mobility through reinforcing weight and stress bearing bones and impeding tumor growth.
Educational Goals / Teaching Points
Review the role of ablation and consolidation techniques in palliative soft tissue and osseous metastatic disease management, present a pictorial review of application in a variety of cases, and discuss the technical considerations, benefits, and limitations of treatment.
Key Anatomic/Physiologic Issues and Imaging Findings/Techniques
We will highlight our current practice in the application of ablation and tumor consolidation in soft tissue and osseous lesions. A series of cases will highlight individual patient pathways with a tailored treatment approach, while highlighting key learning points and the safety and efficacy in minimally invasive procedures.
Conclusion
Radiologists will understand the role of ablation and tumor consolidation plays as adjunct therapy in palliative pain management and the preventions of skeletal-related events.
